World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
132
Citations
58301
World Ranking
2332
National Ranking
1317

Overview

Carlos A. Zarate is affiliated with the National Institutes of Health in the United States. Their research contributions primarily focus on neuroscience, medicine, and psychology, with a substantial number of publications addressing pharmacology, biological psychiatry, cognitive neuroscience, experimental and cognitive psychology, and cellular and molecular neuroscience.

The scientist's work covers a broad range of topics including:

  • Treatment of Major Depression
  • Tryptophan and brain disorders
  • Mental Health Research Topics
  • Functional Brain Connectivity Studies
  • Suicide and Self-Harm Studies
  • Neuroscience and Neuropharmacology Research
  • Stress Responses and Cortisol

Carlos A. Zarate's recent notable publications include:

  • "Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation," 2021, American Journal of Psychiatry
  • "Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis," 2020, Journal of Affective Disorders
  • "Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability," 2021, Molecular Psychiatry
  • "ENIGMA MDD: seven years of global neuroimaging studies of major depression through worldwide data sharing," 2020, Translational Psychiatry
  • "The role of dissociation in ketamine's antidepressant effects," 2020, Nature Communications

The scientist frequently publishes in leading venues such as:

  • Biological Psychiatry
  • Journal of Affective Disorders
  • Molecular Psychiatry
  • Neuropsychopharmacology
  • Translational Psychiatry

Frequent co-authors collaborating with Carlos A. Zarate include:

  • Elizabeth D. Ballard
  • Jessica R. Gilbert
  • Bashkim Kadriu
  • Jennifer W. Evans
  • Todd D. Gould

Best Publications

  • A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression

    Carlos A. Zarate;Jaskaran B. Singh;Paul J. Carlson;Nancy E. Brutsche

  • NMDAR inhibition-independent antidepressant actions of ketamine metabolites

    Panos Zanos;Ruin Moaddel;Patrick J. Morris;Polymnia Georgiou

  • Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors

    Sungho Maeng;Carlos A. Zarate;Jing Du;Robert J. Schloesser

  • Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms

    Panos Zanos;Ruin Moaddel;Patrick J. Morris;Lace M. Riggs

  • A Randomized Add-on Trial of an N-methyl-d-aspartate Antagonist in Treatment-Resistant Bipolar Depression

    Nancy Diazgranados;Lobna Ibrahim;Nancy E. Brutsche;Andrew Newberg

  • Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

    Gerard Sanacora;Carlos A. Zarate;John H. Krystal;Husseini K. Manji

  • Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial.

    Carlos A. Zarate;Nancy E. Brutsche;Lobna Ibrahim;Jose Franco-Chaves

  • The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

    Isabella Pacchiarotti;David J. Bond;Ross J. Baldessarini;Willem A. Nolen

  • Cortical abnormalities in bipolar disorder : An MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group

    D P Hibar;L T Westlye;L T Westlye;N T Doan;N T Doan;N Jahanshad

  • The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis

    Samuel T. Wilkinson;Elizabeth D. Ballard;Michael H. Bloch;Sanjay J. Mathew

  • Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.

    Husseini K Manji;Jorge A Quiroz;Jonathan Sporn;Jennifer L Payne

  • Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder.

    Nancy DiazGranados;Lobna A. Ibrahim;Nancy E. Brutsche;Rezvan Ameli

  • The McLean-Harvard first-episode mania study: Prediction of recovery and first recurrence

    Mauricio Tohen;Carlos A. Zarate;John Hennen;Hari Mandir Kaur Khalsa

  • Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation

    Roger S McIntyre;Roger S McIntyre;Joshua D Rosenblat;Joshua D Rosenblat;Charles B Nemeroff;Gerard Sanacora

  • Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.

    Mauricio Tohen;Mauricio Tohen;K. N. Roy Chengappa;Trisha Suppes;Carlos A. Zarate

  • Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.

    Mauricio Tohen;Terence A. Ketter;Carlos A. Zarate;Trisha Suppes

  • A Double-Blind, Placebo-Controlled Study of Memantine in the Treatment of Major Depression

    Carlos A. Zarate;Jaskaran B. Singh;Jorge A. Quiroz;Georgette De Jesus

  • Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone.

    Mauricio Tohen;K N Roy Chengappa;Trisha Suppes;Robert W Baker

  • International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder.

    Ayal Schaffer;Erkki T. Isometsä;Leonardo Tondo;Doris H Moreno

  • Pramipexole for bipolar II depression: a placebo-controlled proof of concept study.

    Carlos A Zarate;Jennifer L Payne;Jaskaran Singh;Jorge A Quiroz

Frequent Co-Authors

Rodrigo Machado-Vieira
Rodrigo Machado-Vieira The University of Texas Health Science Center at Houston
David A. Luckenbaugh
David A. Luckenbaugh National Institutes of Health
Elizabeth D. Ballard
Elizabeth D. Ballard National Institutes of Health
Husseini K. Manji
Husseini K. Manji National Institutes of Health
Wayne C. Drevets
Wayne C. Drevets Johnson & Johnson (United States)
Mark J. Niciu
Mark J. Niciu University of Iowa
Todd D. Gould
Todd D. Gould University of Maryland, Baltimore
Mauricio Tohen
Mauricio Tohen University of New Mexico
Maura L. Furey
Maura L. Furey Janssen (Belgium)
Ruin Moaddel
Ruin Moaddel National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to Medicine can open diverse career options in healthcare. Many students interested in leadership roles choose cahme accredited mha online programs. These programs allow you to study health administration and management from anywhere, providing flexibility for busy schedules.

For nurses looking to advance without stepping away from work, online RN to BSN degrees offer a solution. Some top rn to bsn no clinical hours programs eliminate the need for traditional clinical experiences, making them accessible to working professionals.

If you’re aiming for advanced practice or leadership in nursing, consider Doctor of Nursing Practice (DNP) programs. The accelerated dnp programs let you earn your degree faster, so you can move quickly into higher clinical or organizational roles. Budget is often a concern, but there are cheapest dnp programs available online that balance cost, speed, and academic credibility.

Exploring these online pathways helps you tailor your education to your career goals, while balancing work and family commitments.

Best Scientists Citing Carlos A. Zarate

Trending Scientists

Recently Published Articles